Glyxambi Prices — US Pharmacy Cost vs Canada

At the US pharmacies in our data, the lowest listed discount-card price for Glyxambi is around $239.95. Prices vary by pharmacy, dosage, and pack size, so use the table above to compare specific options near you.

Canadian pharmacy listings in our data show Glyxambi priced from about $0.480 per tablet (converted to USD), before shipping. Pack size and pharmacy both affect the final total — see the Canada pricing table for specifics.

Drug pricing is set separately in each country through different negotiation, regulatory, and distribution systems, so the same medication can legitimately carry different price tags on either side of the border. Check the comparison table above for the specific numbers on Glyxambi.

Generic and brand-name pricing for Glyxambi is broken out in the tables above where both exist in our data. Generic versions are typically the lower-cost option, but availability depends on the specific formulation and dosage.

The cost of Glyxambi with insurance depends entirely on the specific details of your health plan, including your deductible, copay, or coinsurance requirements. To get an accurate estimate, ask your pharmacist to run your prescription through your insurance. It's also worth checking the discounted cash price available through various savings programs, as this price can sometimes be lower than your insurance copay, potentially offering additional savings.

Coverage for Glyxambi under Medicare depends on your specific Part D or Medicare Advantage plan's formulary. The cost to you, whether a copay or coinsurance, will vary based on your plan's phase of coverage (like deductible or catastrophic). You should consult your plan's drug list or speak with your plan provider for precise details. To ensure you're getting the best available price, you can compare your Medicare cost against the discounted cash price offered by pharmacy savings programs at the time of each refill.

No, a generic equivalent for Glyxambi is not currently available. Glyxambi is a brand-name medication jointly manufactured by Boehringer Ingelheim Pharmaceuticals Inc. and Eli Lilly and Company.